ProfileGDS4459 / ENSG00000067225
TitleIntraportal tacrolimus flushing effect on liver allograft
OrganismHomo sapiens


flushed with tacrolimus flushed with albumin control GSM623464 GSM623465 GSM623466 GSM623467 GSM623468 GSM623469 GSM623470 GSM623471 GSM623472 GSM623473 GSM623474 GSM623475 GSM623476 GSM623477 GSM623478 GSM623479 GSM623480 42% 60% 65% 56% 48% 68% 72% 70% 65% 68% 75% 69% 69% 71% 46% 65% 49% sort by protocol Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM623464group A, liver allograft wedge biopsie tacrolimus treatment 14.1642
GSM623465group A, liver allograft wedge biopsie tacrolimus treatment 24.7460
GSM623466group A, liver allograft wedge biopsie tacrolimus treatment 35.0865
GSM623467group A, liver allograft wedge biopsie tacrolimus treatment 44.6956
GSM623468group A, liver allograft wedge biopsie tacrolimus treatment 54.3148
GSM623469group A, liver allograft wedge biopsie tacrolimus treatment 65.1468
GSM623470group A, liver allograft wedge biopsie tacrolimus treatment 75.5672
GSM623471group A, liver allograft wedge biopsie tacrolimus treatment 85.3570
GSM623472group A, liver allograft wedge biopsie tacrolimus treatment 95.165
GSM623473group A, liver allograft wedge biopsie tacrolimus treatment 105.2768
GSM623474group B, liver allograft wedge biopsie placebo treatment 15.5875
GSM623475group B, liver allograft wedge biopsie placebo treatment 25.3769
GSM623476group B, liver allograft wedge biopsie placebo treatment 35.369
GSM623477group B, liver allograft wedge biopsie placebo treatment 45.2371
GSM623478group B, liver allograft wedge biopsie placebo treatment 54.1846
GSM623479group B, liver allograft wedge biopsie placebo treatment 64.9665
GSM623480group B, liver allograft wedge biopsie placebo treatment 74.3649